Best Peptides for Men

Men searching for peptides tend to land on four different goals at once: losing fat, adding muscle, raising testosterone, and libido. Those four goals sit on four different parts of the body, controlled by different hormone systems, and the trial evidence behind them is just as uneven. This guide keeps the goals separate and ranks the compounds inside each one by what was actually measured, rather than by how often a name comes up in a gym forum.

Summary

Body composition: the same approved medicines as everyone else

Semaglutide, tirzepatide and liraglutide carry the largest trial programmes of any compound in this library, but none of the pivotal papers, STEP-1, SURMOUNT-1 or SCALE, reported results separately for men. Tesamorelin is the one GH-axis compound with real phase 3 human data, though its approval is narrow: it reduces visceral fat specifically in adults with HIV-associated lipodystrophy, and the label states it is not indicated for weight loss in general. GH secretagogues sold for a leaner look, ipamorelin, CJC-1295, MK-677, the GHRPs, have much thinner human trial records, mostly old studies in older or ill adults measuring GH and IGF-1, not body composition in healthy men. The best peptides for muscle growth and fat loss guide ranks all of them against each other.

Testosterone and the HPG axis: what actually raises it, and what does not

This is the point men most often get wrong. hCG mimics luteinising hormone directly at the testes and is an approved medicine for hypogonadotropic hypogonadism; gonadorelin is synthetic GnRH, which worked as a pituitary diagnostic before its US products were discontinued; kisspeptin sits one step higher, and a 2005 study found a 90-minute infusion in six healthy men raised mean LH from 4.2 to 10.8 U/L compared with saline, along with FSH and testosterone. All three act on the hypothalamic-pituitary-gonadal axis, in that order.

GH secretagogues do not. Ipamorelin, CJC-1295, sermorelin, tesamorelin, GHRP-2, GHRP-6 and MK-677 work through the ghrelin or GHRH receptor in the pituitary, a system that governs growth hormone and IGF-1, not LH, FSH or testosterone. None of their published trials measured testosterone, because it was never the axis they were designed to touch. The best peptides for testosterone guide covers what each HPG-axis compound's trials actually measured, in more depth than fits here.

Sexual health: kisspeptin's own data, and PT-141's explicit exclusion of men

Kisspeptin has the most direct human evidence for male sexual desire in this library. A 2017 study found kisspeptin increased limbic brain activity specifically when 29 young men viewed sexual and couple-bonding images, and a 2023 randomised trial in 32 men with hypoactive sexual desire disorder reported greater activation of sexual brain networks and penile rigidity up to 56% higher than placebo during erotic videos. Both were single infusions in a research setting, not a treatment course.

PT-141 (bremelanotide) is not an option here in the way it is for women: the FDA label for Vyleesi covers only premenopausal women with HSDD and states explicitly it is not indicated for men. Earlier research tested it in men with erectile dysfunction, without leading to an approval. Melanotan-2 does raise arousal in men, since it was the molecule PT-141 was built from, but it was never approved anywhere and carries a real dermatology case-report record of new and changing moles, along with warnings from the UK's MHRA and Australia's TGA. The best peptides for libido guide ranks all three options against each other.

Safety notes across the four goals

Each category carries a different risk profile, and mixing them up leads to the wrong monitoring. The GLP-1 medicines share a class boxed warning on thyroid C-cell tumours seen in rodents, and their common side effects are gastrointestinal; see the side effect management guide for what the trials reported. Tesamorelin's label lists joint pain, injection-site reactions and fluid retention, and it calls for glucose monitoring since it raises IGF-1. hCG's label lists headache, irritability, gynaecomastia and, in fertility use, ovarian hyperstimulation, though that risk applies to female patients rather than the men who use it alongside testosterone therapy. Kisspeptin's only reported safety data comes from short, well-tolerated single infusions, so nothing is known about repeated use. Melanotan-2 is the one compound here with a documented pattern of harm outside the lab: new or changing moles and, in case reports, melanoma. Bloodwork in the Philippines covers where to get LH, FSH, testosterone, IGF-1 and glucose checked locally, which matters more for these compounds than for most others in this library, since the whole point of the HPG-axis and GH-axis groups is a hormone change that only bloodwork can confirm.

Status in the Philippines

Ozempic, Wegovy, Mounjaro and hCG are registered or sold as prescription medicines here; prescribing any of them, along with gonadorelin where a physician chooses to use it off-label, belongs with a licensed Philippine physician. Tesamorelin, kisspeptin and melanotan-2 have no FDA Philippines registration and circulate only through research-peptide suppliers. For male athletes specifically, hCG and gonadorelin are both listed under the WADA Prohibited List's S2 category, banned at all times, and GHRP-2 and GHRP-6 are named separately under the same section for their effect on growth hormone.